209 related articles for article (PubMed ID: 2507170)
1. Activation of human peripheral blood-derived monocytes by OK-432 (Streptococcus pyogenes): augmented cytotoxicity and secretion of TNF and synergy with rIFN-gamma.
Bonavida B; Jewett A
Cell Immunol; 1989 Oct; 123(2):373-83. PubMed ID: 2507170
[TBL] [Abstract][Full Text] [Related]
2. TNF-alpha is secreted by monocytes in transit to become macrophages, but not by peripheral blood monocytes, following OK-432 (lyophilized S. pyogenes) stimulation.
Olsnes C; Stavang H; Olofsson J; Aarstad HJ
Scand J Immunol; 2007 Dec; 66(6):684-93. PubMed ID: 18021366
[TBL] [Abstract][Full Text] [Related]
3. Peripheral blood monocytes derived from HIV+ individuals mediate antibody-dependent cellular cytotoxicity (ADCC).
Jewett A; Bonavida B
Clin Immunol Immunopathol; 1990 Feb; 54(2):192-9. PubMed ID: 2104787
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of NK activation by OK-432 (Streptococcus pyogenes). I. Spontaneous release of NKCF and augmentation of NKCF production following stimulation with NK target cells.
Bonavida B; Katz J; Hoshino T
Cell Immunol; 1986 Oct; 102(1):126-35. PubMed ID: 3492275
[TBL] [Abstract][Full Text] [Related]
5. Comparative analysis of the priming effect of human interferon-gamma, -alpha, and -beta on synergism with muramyl dipeptide analog for anti-tumor expression of human blood monocytes.
Utsugi T; Sone S
J Immunol; 1986 Feb; 136(3):1117-22. PubMed ID: 3079797
[TBL] [Abstract][Full Text] [Related]
6. Production of tumor necrosis factor (TNF) by monocytes from cancer patients and healthy subjects induced by OK-432 in vitro, and its augmentation by human interferon gamma.
Sekimoto M; Kokunai I; Shimano T; Kobayashi T; Takeda T; Haruna N; Yamamoto A; Mori T
J Clin Lab Immunol; 1988 Nov; 27(3):115-20. PubMed ID: 3150012
[TBL] [Abstract][Full Text] [Related]
7. Activation of human peripheral-blood-derived monocytes by cis-diamminedichloroplatinum: enhanced tumoricidal activity and secretion of tumor necrosis factor-alpha.
Gan XH; Jewett A; Bonavida B
Nat Immun; 1992; 11(3):144-55. PubMed ID: 1392402
[TBL] [Abstract][Full Text] [Related]
8. Endogenous production of tumor necrosis factor in normal mice and human cancer patients by interferons and other cytokines combined with biological response modifiers of bacterial origin.
Satoh M; Inagawa H; Shimada Y; Soma G; Oshima H; Mizuno D
J Biol Response Mod; 1987 Oct; 6(5):512-24. PubMed ID: 2445926
[TBL] [Abstract][Full Text] [Related]
9. Involvement of tumor necrosis factor in cytotoxicity mediated by human monocytes.
Nissen-Meyer J; Hofsli E; Espevik T; Austgulen R
Nat Immun Cell Growth Regul; 1988; 7(5-6):266-79. PubMed ID: 3146697
[TBL] [Abstract][Full Text] [Related]
10. Effect of antisera against recombinant tumor necrosis factor and the monocyte-derived cytotoxin(s) on monocyte-mediated killing of various tumor cells.
Nissen-Meyer J; Espevik T
Cell Immunol; 1987 Oct; 109(2):384-96. PubMed ID: 3478143
[TBL] [Abstract][Full Text] [Related]
11. Generation of activated killer-like cells by OK-432-mediated production of interleukin 1, interleukin 2, and interferon-gamma in vitro.
Ujiie T
Jpn J Exp Med; 1987 Dec; 57(6):333-8. PubMed ID: 3131563
[TBL] [Abstract][Full Text] [Related]
12. Effects of platelet-activating factor on peripheral blood monocytes: induction and priming for TNF secretion.
Bonavida B; Mencia-Huerta JM; Braquet P
J Lipid Mediat; 1990; 2 Suppl():S65-76. PubMed ID: 2133285
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of natural killer cell activity in human immunodeficiency virus-infected subjects by in vitro treatment with biologic response modifier OK-432.
Huang XL; Fan Z; Murayama T; Rinaldo C
Clin Diagn Lab Immunol; 1995 Jan; 2(1):91-7. PubMed ID: 7719919
[TBL] [Abstract][Full Text] [Related]
14. In vitro augmentation of human natural killer (NK) cell activity by a streptococcal preparation OK-432 and its extracts, protein M and polysaccharides.
Wakasugi H; Oshimi K; Kasahara T; Miyata M; Morioka Y
Int Arch Allergy Appl Immunol; 1982; 67(4):322-8. PubMed ID: 7040254
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of human monocyte cytotoxicity by both interferon-gamma and -beta and comparison to other stimuli.
Sharon N; Shoham J; Passwell JH
Int J Immunopharmacol; 1989; 11(7):743-9. PubMed ID: 2513281
[TBL] [Abstract][Full Text] [Related]
16. Cytokine-inducing activity and antitumor effect of a liposome-incorporated interferon-gamma-inducing molecule derived from OK-432, a streptococcal preparation.
Okamoto M; Gohda H; Ohe G; Yoshida H; Matsuno T; Saito M; Sato M
J Immunother; 2000 Jan; 23(1):94-103. PubMed ID: 10687142
[TBL] [Abstract][Full Text] [Related]
17. Role of interferon gamma and tumour necrosis factor alpha in monocyte-mediated cytostasis and cytotoxicity against a human histiocytic lymphoma cell line.
van de Loosdrecht AA; Ossenkoppele GJ; Beelen RH; Broekhoven MG; Langenhuijsen MM
Cancer Immunol Immunother; 1992; 34(6):393-8. PubMed ID: 1563017
[TBL] [Abstract][Full Text] [Related]
18. Spontaneous cytotoxicity and tumor necrosis factor production by peripheral blood monocytes from AIDS patients.
Wright SC; Jewett A; Mitsuyasu R; Bonavida B
J Immunol; 1988 Jul; 141(1):99-104. PubMed ID: 3132506
[TBL] [Abstract][Full Text] [Related]
19. In vitro augmentation of natural killing activity by OK-432.
Uchida A; Micksche M
Int J Immunopharmacol; 1981; 3(4):365-75. PubMed ID: 6174467
[TBL] [Abstract][Full Text] [Related]
20. Synergistic effects of TGIF and interferon gamma (IFN-gamma) on tumor cell growth. TGIF and IFN-gamma.
Katano M; Yamamoto H; Nakamura M; Matsuo T; Hisatsugu T
Biotherapy; 1990; 2(1):33-40. PubMed ID: 2119202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
